Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults.

Race/sex differences are observed in cardiometabolic disease (CMD) risk and prevalence in the context of treated, chronic HIV infection, and these differences could be exacerbated by disparities in obesity prevalence. We sought to determine the effect of obesity on these disparities among people living with HIV. Prevalence of CMD (dyslipidemia, cardiovascular disorders, hypertension, diabetes, chronic kidney disease) was determined for patients seen at the University of Alabama at Birmingham HIV clinic between 7/2010 and 6/2011. Staged logistic regression was used to examine the impact of race/sex on comorbidities adjusting for key confounders including/excluding obesity (body mass index ≥30 kg/m(2)). Of 1,800 participants, 77% were male, 54% were black, and 25% were obese. Obesity prevalence differed by race/sex: black women 49%, black men 24%, white women 24%, white men 15% (p<0.01). Compared to white men, other groups had reduced odds for dyslipidemia and cardiovascular disorders (p<0.01). Black men had increased odds for hypertension and chronic kidney disease, while black women had a nearly 2-fold increased odds for diabetes and hypertension (all at p<0.01). The associations of black women with diabetes and hypertension were attenuated when obesity was included in the models. Other group differences remained significant. Disparities in obesity prevalence do not explain race/sex differences in all CMD among people with HIV. Obesity accounted for associations with diabetes/hypertension for black women, who may benefit from weight reduction to decrease disease risk. Further investigations into the etiology and treatment of CMD in people living with HIV should consider unique race/sex treatment issues.

[1]  S. Chow,et al.  Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. , 2013, AIDS research and human retroviruses.

[2]  K. Flegal,et al.  Prevalence of obesity among adults: United States, 2011-2012. , 2013, NCHS data brief.

[3]  Hiroto Utsunomiya,et al.  Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. , 2009, JACC. Cardiovascular imaging.

[4]  Katherine M Flegal,et al.  Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. , 2012, JAMA.

[5]  Gitte Pedersen,et al.  Survival of Persons with and without HIV Infection in Denmark, 19952005 , 2007, Annals of Internal Medicine.

[6]  C. Tremblay,et al.  Association Between HIV Infection, Antiretroviral Therapy, and Risk of Acute Myocardial Infarction: A Cohort and Nested Case–Control Study Using Québec's Public Health Insurance Database , 2011, Journal of acquired immune deficiency syndromes.

[7]  B. Starfield,et al.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. , 2002, Archives of internal medicine.

[8]  V. Kristiansen,et al.  Roux-en-Y gastric bypass alleviates hypertension and is associated with an increase in mid-regional pro-atrial natriuretic peptide in morbid obese patients , 2015, Journal of hypertension.

[9]  A. Ganesan,et al.  Obesity among patients with HIV: the latest epidemic. , 2008, AIDS patient care and STDs.

[10]  A. Dobs,et al.  Changes in the incidence and predictors of wasting syndrome related to human immunodeficiency virus infection, 1987-1999. , 2002, American journal of epidemiology.

[11]  A. V. D. Velde Reverse cholesterol transport: From classical view to new insights , 2010 .

[12]  M. Vinikoor,et al.  Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. , 2013, AIDS research and human retroviruses.

[13]  Hang Lee,et al.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  A. Westfall,et al.  Multimorbidity Patterns in HIV-Infected Patients: The Role of Obesity in Chronic Disease Clustering , 2012, Journal of acquired immune deficiency syndromes.

[15]  A. Berghold,et al.  Long-term effects of weight-reducing diets in hypertensive patients. , 2011, The Cochrane database of systematic reviews.

[16]  Mardge H. Cohen,et al.  Trends in Mortality and Causes of Death Among Women With HIV in the United States: A 10-Year Study , 2009, Journal of acquired immune deficiency syndromes.

[17]  Anson,et al.  DIET , LIFESTYLE , AND THE RISK OF TYPE 2 DIABETES MELLITUS IN WOMEN , 2001 .

[18]  Vahram Ghushchyan,et al.  Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. , 2005, Diabetes care.

[19]  J. Shikany,et al.  Racial/ethnic disparities in association between dietary quality and incident diabetes in postmenopausal women in the United States: the Women's Health Initiative 1993–2005 , 2014, Ethnicity & health.

[20]  M. Budoff,et al.  Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study , 2008, AIDS.

[21]  Mardge H. Cohen,et al.  Prevalence and correlates of elevated body mass index among HIV-positive and HIV-negative women in the Women's Interagency HIV Study. , 2009, AIDS patient care and STDs.

[22]  Tyler H Tate,et al.  HIV Infection and Obesity: Where Did All the Wasting Go? , 2012, Antiviral therapy.

[23]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[24]  Sally S Bebawy,et al.  Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy. , 2013, AIDS research and human retroviruses.

[25]  I. Frank,et al.  HIV infection and glycemic response to newly initiated diabetic medical therapy , 2012, AIDS.

[26]  A. van der Velde Reverse cholesterol transport: from classical view to new insights. , 2010, World journal of gastroenterology.

[27]  A. Avenell,et al.  Effects of Weight Loss in Overweight/Obese Individuals and Long-Term Hypertension Outcomes: A Systematic Review , 2005, Hypertension.

[28]  A. Ganesan,et al.  Prevalence and factors associated with renal dysfunction among HIV-infected patients. , 2010, AIDS patient care and STDs.

[29]  O. Kirk,et al.  Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study) , 2009, Circulation.

[30]  M. Reiser,et al.  18F-FDG PET/CT Identifies Patients at Risk for Future Vascular Events in an Otherwise Asymptomatic Cohort with Neoplastic Disease , 2009, Journal of Nuclear Medicine.

[31]  E. Demerath,et al.  Physical Activity Attenuates the Influence of FTO Variants on Obesity Risk: A Meta-Analysis of 218,166 Adults and 19,268 Children , 2011, PLoS medicine.

[32]  Anne L. Taylor,et al.  Coronary heart disease in HIV-infected individuals. , 2003, Journal of acquired immune deficiency syndromes.

[33]  M. Magoni,et al.  The evolving burden of HIV infection compared with other chronic diseases in northern Italy * , 2011, HIV medicine.

[34]  J. Chmiel,et al.  Disparities in Prevalence of Key Chronic Diseases by Gender and Race/Ethnicity among Antiretroviral-Treated HIV-Infected Adults in the Us , 2012, Antiviral therapy.

[35]  A. Berghold,et al.  Long-term effects of weight-reducing drugs in hypertensive patients. , 2009, The Cochrane database of systematic reviews.

[36]  A. Mocroft,et al.  Changes in AIDS-defining illnesses in a London Clinic, 1987-1998. , 1999, Journal of acquired immune deficiency syndromes.

[37]  Joseph K McLaughlin,et al.  Obesity and risk for chronic renal failure. , 2006, Journal of the American Society of Nephrology : JASN.

[38]  David E. Vance,et al.  Aging With HIV: A Cross‐Sectional Study of Comorbidity Prevalence and Clinical Characteristics Across Decades of Life , 2011, The Journal of the Association of Nurses in AIDS Care : JANAC.

[39]  Richard D Moore,et al.  End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 , 2007, AIDS.

[40]  J. Manson,et al.  Determinants of Racial/Ethnic Disparities in Incidence of Diabetes in Postmenopausal Women in the U.S. , 2012, Diabetes Care.

[41]  M. Synnestvedt,et al.  A Tale of 2 Epidemics: The Intersection Between Obesity and HIV Infection in Philadelphia , 2005, Journal of acquired immune deficiency syndromes.

[42]  S. Cole,et al.  Racial Disparities in HIV Virologic Failure: Do Missed Visits Matter? , 2009, Journal of Acquired Immune Deficiency Syndromes.

[43]  K. Furie,et al.  Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2007, Circulation.

[44]  J. Manson,et al.  Ethnicity, Obesity, and Risk of Type 2 Diabetes in Women , 2006, Diabetes Care.

[45]  John T Brooks,et al.  Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study , 2006, Journal of acquired immune deficiency syndromes.